2Wang JJ,Li YF,Jin YY,et al. Effects of Epstein-Barr vi-rus on the development of dendritic cells derived fromcord blood monocytes:an essential role for apoptosis[J],Braz J Infect Dis,2012,16(l) :19-26.
2Villadangos JA, Young L. Antigen-presentation properties of plasmacytoid dendritic cells[J]. Immunity, 2008, 29 (3) : 352 - 361.
3Subklewe M, Paludan C, Tsang ML, et al. Dendritic cells crosspresent latency gcne products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells[J]. J Exp Med, 2001, 193(3): 405-411.
4Li L, Liu D, Hutt-Fletcher L, et al. Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte maeruphage-colonystimulating factor and interleukin-4 [ J ]. Blood, 2002, 99 (10) : 3725 - 3734.
5Fernandez-Luna JL. Apoptosis regulators as targets for cancer therapy[J]. Clin Transl Oncol, 2007, 9(9) : 555 -562.
6Decker P, Muller S. Modulating poly (ADP-ribose) polymerase activity:potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress[J]. Curr Pharm Biotechnol, 2002, 3 (3) : 275 - 283.
7Tobon GJ, Alard JE, Youinou P, et al. Are autoantibodies triggering endothelial cell apoptosis really pathogenic [J] ? Autoimmun Rev, 2009, 8(7): 605-610.
9Yamashite N , Kimura H , Marishima T. Virological as pects of Epstein-Barr virus infections[J]. Acta Med Okayama, 2005, 59:239-246.
10Boussiotis VA, Freeman GJ, Gray G, etal. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance [J]. J Exp Med, 1993,178:1753 -1763.
